Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Naomi Kawashima, M.D., Ph.D.

Concepts (147)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Myeloid, Acute11202436361.620 Why?
fms-Like Tyrosine Kinase 3420244960.980 Why?
Core Binding Factor Alpha 2 Subunit320243520.710 Why?
Hematopoietic Stem Cell Transplantation8202157520.700 Why?
DNA Repeat Expansion12020740.680 Why?
Chromosomes, Human, Pair 21120182280.600 Why?
Chromosomes, Human, Pair 8120184510.540 Why?
Donor Selection120182420.500 Why?
Gene Expression Regulation, Leukemic120186570.480 Why?
Oncogene Proteins, Fusion2201816090.430 Why?
Thrombocythemia, Essential220241140.420 Why?
Translocation, Genetic1201813920.410 Why?
Hematologic Neoplasms3201819260.370 Why?
Mutation82024302100.350 Why?
Tissue and Organ Procurement120189880.320 Why?
Repressor Proteins2202429740.310 Why?
Peripheral Blood Stem Cell Transplantation220172660.240 Why?
Leukemia, Large Granular Lymphocytic12024240.230 Why?
Janus Kinase 2220245620.230 Why?
Hemoglobinuria, Paroxysmal12024860.220 Why?
DNA-Binding Proteins3202496000.210 Why?
Calreticulin120241110.210 Why?
Receptors, Thrombopoietin120241580.210 Why?
Transplantation, Homologous3202048600.190 Why?
Neoplasms, Second Primary2201810560.170 Why?
Magnolia1201930.170 Why?
Hematologic Diseases220215000.160 Why?
Transcription Factors12018121280.160 Why?
Clone Cells1202216700.150 Why?
Myeloproliferative Disorders120246150.150 Why?
Myelodysplastic-Myeloproliferative Diseases12018150.150 Why?
Photopheresis12018350.150 Why?
Gene Frequency1202436230.140 Why?
Leukemia, Promyelocytic, Acute120182490.140 Why?
Japan2201814140.130 Why?
Chimerism120171540.130 Why?
Adolescent102024888080.130 Why?
Proto-Oncogene Proteins c-kit120207230.130 Why?
Germ-Line Mutation1202418850.130 Why?
Iodine120182850.130 Why?
Tretinoin120185240.120 Why?
Survival Rate32018128220.120 Why?
Graft vs Host Disease2201830790.120 Why?
Cyclin-Dependent Kinase Inhibitor p16120187020.120 Why?
Young Adult82024598580.120 Why?
Busulfan120152640.120 Why?
Bone Marrow Cells1202224110.120 Why?
Remission Induction1202024130.110 Why?
Middle Aged1620242230350.110 Why?
Staining and Labeling1201810720.110 Why?
Protein Kinase Inhibitors2202156950.110 Why?
Bacteremia120219870.110 Why?
Alleles1202468920.110 Why?
Waiting Lists120187790.100 Why?
Adult1420242231100.100 Why?
Transplantation Conditioning2201716350.100 Why?
Aged1120241711700.090 Why?
Male1720243638800.090 Why?
Disease-Free Survival2201868400.090 Why?
Female1820243961740.090 Why?
Thrombosis1202429530.090 Why?
Humans2420247660190.080 Why?
HLA Antigens1201513380.080 Why?
Kaplan-Meier Estimate1202065060.080 Why?
DNA Mutational Analysis1201841120.080 Why?
Cyclophosphamide1201522320.080 Why?
Dioxygenases220243540.080 Why?
Anticoagulants1202448540.080 Why?
Recurrence1202184940.070 Why?
Combined Modality Therapy1202085240.070 Why?
Disease Progression32024136140.070 Why?
Esophageal Neoplasms1201816590.070 Why?
Drug Resistance, Neoplasm2201953340.070 Why?
Sequence Deletion2201914940.060 Why?
Length of Stay1201864890.060 Why?
Genetic Variation1201966110.060 Why?
Graft Rejection1201745040.060 Why?
Time Factors42018401000.060 Why?
Patient Readmission1201832830.060 Why?
Point Mutation2201915910.060 Why?
Treatment Outcome32020652030.060 Why?
Anemia, Hemolytic120241640.050 Why?
Disease Models, Animal12022183210.050 Why?
Prognosis22020299050.050 Why?
Aged, 80 and over22024594970.050 Why?
Registries1201883430.050 Why?
Bacillus cereus12021360.050 Why?
Tumor Suppressor Protein p532202429450.040 Why?
GTP Phosphohydrolases120245240.040 Why?
Core Binding Factor beta Subunit12020420.040 Why?
Segmental Duplications, Genomic12019200.040 Why?
DNA, Chloroplast1201950.040 Why?
Retrospective Studies32024815440.040 Why?
Phylogeography12019710.040 Why?
Plant Leaves120191530.040 Why?
Protein-Tyrosine Kinases2201824250.040 Why?
Myosin Heavy Chains120204030.040 Why?
Prebiotics12018410.040 Why?
HL-60 Cells120183640.040 Why?
Proto-Oncogene Proteins c-myb12018820.040 Why?
Spliceosomes120181160.040 Why?
Founder Effect120181850.040 Why?
Graft vs Leukemia Effect120171220.040 Why?
Philadelphia Chromosome120171190.040 Why?
Microsatellite Repeats120197840.030 Why?
Lymphocyte Transfusion120172360.030 Why?
Genetic Predisposition to Disease12018180750.030 Why?
GPI-Linked Proteins120174720.030 Why?
Antilymphocyte Serum120174920.030 Why?
Fusion Proteins, bcr-abl120174290.030 Why?
Ecosystem120194890.030 Why?
Cell Line, Tumor22024170710.030 Why?
Mice12022818380.030 Why?
Neoplasms12024223360.030 Why?
Anemia1202415140.030 Why?
Cell Transformation, Neoplastic1202428380.030 Why?
Tacrolimus120177530.030 Why?
Biological Evolution1201910750.030 Why?
Child22018805670.030 Why?
Prospective Studies42020548040.030 Why?
Chronic Disease2201893510.030 Why?
Neoplasm, Residual1201710090.030 Why?
Drug Resistance1201815920.020 Why?
Phylogeny1201928380.020 Why?
Down-Regulation1201829270.020 Why?
Reverse Transcriptase Polymerase Chain Reaction1201745650.020 Why?
Proteomics1202439070.020 Why?
Animals120221688010.020 Why?
Follow-Up Studies22024392330.020 Why?
Leukocytes1201720300.020 Why?
Glucocorticoids1201821560.020 Why?
Membrane Proteins1202478500.020 Why?
Feasibility Studies1201753010.020 Why?
Proto-Oncogene Proteins1201845200.020 Why?
Survival Analysis12018100890.020 Why?
Immunosuppressive Agents1201742130.010 Why?
Immunohistochemistry12018110350.010 Why?
Epigenesis, Genetic1201838210.010 Why?
Clinical Trials as Topic1201980370.010 Why?
Gene Expression Regulation, Neoplastic1201886130.010 Why?
Anti-Bacterial Agents1202174740.010 Why?
Gene Expression Profiling1201895250.010 Why?
Signal Transduction12019236000.010 Why?
Infant12018364240.010 Why?
Child, Preschool12018425090.010 Why?
Antineoplastic Agents12018136350.010 Why?
Risk Factors12018748370.010 Why?
Kawashima's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (147)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.